Ompracel-D 10mg/20mg Capsule is a combination medication containing Domperidone 10mg and Omeprazole 20mg, indicated for the management of gastrointestinal disorders characterized by acid reflux and motility disturbances. Omeprazole, a proton pump inhibitor, acts by suppressing gastric acid secretion through selective inhibition of the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby providing symptomatic relief and promoting healing of erosive esophagitis and peptic ulcers. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by accelerating gastric emptying and increasing lower esophageal sphincter tone, which aids in reducing symptoms such as nausea, vomiting, bloating, and early satiety. This combination is particularly beneficial in patients suffering from gastroesophageal reflux disease (GERD) with associated delayed gastric emptying. Ompracel-D should be administered as prescribed, typically before meals, to optimize therapeutic outcomes. Caution is advised in patients with cardiac conditions, as Domperidone may prolong the QT interval. It is contraindicated in individuals with known hypersensitivity to either component, prolactinoma, or gastrointestinal hemorrhage. Regular monitoring and adherence to prescribed dosage are essential to minimize adverse effects and ensure efficacy.